Arcadia Investment Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-56
Closed -$9.13K 333
2023
Q3
$9.13K Sell
56
-22
-28% -$5.19K ﹤0.01% 292
2023
Q2
$25.5K Sell
78
-137
-64% -$41.8K 0.01% 256
2023
Q1
$59.3K Hold
215
0.01% 216
2022
Q4
$83.1K Buy
+215
New +$60.6K 0.02% 185

Other funds holding OM

Arcadia Investment Management's OM Position: Q4 2023 in Review

Arcadia Investment Management sold out of Outset Medical (OM) in Q4 2023, closing a stake of 56 shares — an estimated $9.13K sold.

Arcadia Investment Management first reported a position in OM in Q4 2022 and held it in 4 quarters. The position peaked at $83.1K in Q4 2022. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • Arcadia Investment Management reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • Arcadia Investment Management sold 56 Outset Medical shares in Q4 2023, an estimated $9.13K.
  • Arcadia Investment Management first reported a position in Outset Medical in Q4 2022 and held it in 4 quarters.
  • Arcadia Investment Management's Outset Medical position peaked at $83.1K in Q4 2022.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Arcadia Investment Management's 13F filing for Q4 2023, filed 7 Feb 2024.